Real-time enrollment status for this pelizaeus-merzbacher disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 10:32 PM UTC
| NCT Number | NCT06150716 |
| Recruiting Status | Recruiting |
| Condition | Pelizaeus-Merzbacher Disease |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Ionis Pharmaceuticals, Inc. |
| Last Updated on CT.gov | December 12, 2025 (Dec 12, 2025) |
As of July 18, 2026: Clinical trial NCT06150716 is currently recruiting participants. This phase1 study for pelizaeus-merzbacher disease is actively seeking new participants at 3 locations across the United States. The study is sponsored by Ionis Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06150716 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06150716 was last updated Dec 12, 2025 (December 12, 2025). HelloStudys verifies this status automatically.